Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.3835
-0.0275 (-6.69%)
At close: Aug 13, 2025, 4:00 PM
0.3832
-0.0003 (-0.08%)
Pre-market: Aug 14, 2025, 9:07 AM EDT
Biodesix Employees
Biodesix had 273 employees as of December 31, 2024. The number of employees increased by 56 or 25.81% compared to the previous year.
Employees
273
Change (1Y)
56
Growth (1Y)
25.81%
Revenue / Employee
$280,425
Profits / Employee
-$150,469
Market Cap
56.23M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 273 | 56 | 25.81% |
| Dec 31, 2023 | 217 | -28 | -11.43% |
| Dec 31, 2022 | 245 | 27 | 12.39% |
| Dec 31, 2021 | 218 | 18 | 9.00% |
| Dec 31, 2020 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BDSX News
- 4 days ago - Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Biodesix Announces Second Quarter 2025 Results and Highlights - GlobeNewsWire
- 9 days ago - Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 21 days ago - Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 2 months ago - Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs - GlobeNewsWire
- 2 months ago - Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting - GlobeNewsWire
- 3 months ago - Biodesix to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS - GlobeNewsWire